STYRENIX - Styrenix Performance Materials Limited Share Price

The management of Styrenix Performance Materials Limited provided insights into their outlook during the earnings call on February 2, 2026.

The key forward-looking points include:

1. Financial Performance: Total income for Q3 FY '26 was INR 648.8 crores, a decline of 6.2% from INR 692.2 crores in Q3 FY '25. However, EBITDA for the same quarter slightly improved to INR 75.7 crores from INR 75.4 crores, resulting in EBITDA margins increasing to 11.7% from 10.9%. This reflects a focus on improving efficiency despite falling revenues.

2. Expanded Sales Volumes: The company achieved a sales volume increase, reaching 51.1 KT in Q3 FY '26, up 7.6% year-over-year from 47.5 KT, signaling strong demand potentially driven by new product launches.

3. Thailand Operations: The inventory buildup in Thailand led to operational challenges and inventory losses due to price adjustments in raw materials. The management emphasized that around 75% of the recent losses were linked to this inventory valuation, while they expect stabilization and growth as brand validation progresses.

4. Market Dynamics and Pricing Strategy: The management noted that despite competitive pressures from global suppliers, especially from China, they anticipate maintaining stable spreads and demand for their unique products in India and Thailand. A focus on routinely providing customized and validated products should aid in retaining customers.

5. Capacity Utilization and Expansion Plans: The company plans to initiate the first phase of ABS capacity expansion in the second half of FY '27. The expected increase, approximately 50 KT, will help meet demand without adding significant pressure on pricing.

6. Long-term Growth Prospects: Management remains optimistic about long-term growth given the substantial demand in the specialty ABS markets and are continually working on enhancing product approvals and capacity utilization.

Through these discussions, the management has set a cautious yet positive tone for future growth potential against a backdrop of challenging market conditions.

Here are the major questions and their respective answers from the Q&A section of the earnings transcript:

1. Question: Can you elaborate on the inventory buildup in Thailand, particularly regarding the changeover from ABS and SAN? What has changed with the products?

Answer: Yes, Aditya, following our takeover in January '25, we continued producing under the previous brand for a certain period. This allowed us to build inventory while awaiting validations for our new Absolac and Absolan brands. We retained about 90% of prior customers. The product formulations and specifications remain unchanged"”only the branding is new. Inventory buildups were recorded in the quarter they occurred, correlating with our production timeline.

2. Question: What would be the inventory adjustment figure, and how much EBITDA would we have seen without inventory losses?

Answer: Aditya, there isn't a distinct one-time adjustment. The inventory loss reflects the decreased pricing of raw materials and finished goods. Our inventory was valued as per accounting standards. If the cost of raw material drops, it inevitably affects realized revenue. Therefore, the losses stem from anticipated market pricing rather than a one-time issue. Any granular EBITDA figure related to inventory adjustments is not available.

3. Question: What is the status of the approvals for the new GPPS capacity expansion, and how are we geared up for improved volumes given the peak sales season?

Answer: For GPPS, approvals typically take 3 to 9 months, with over 50% of our sales now coming from OEMs. While we are sold out on HIPS, we have additional capacity in GPPS but face challenges selling it fully. In Q3, polystyrene sales rebounded, but overall demand wasn't as strong as projected for the year. We anticipate more robust volume growth from polystyrene in the second half as seasonality kicks in.

4. Question: Given the oversupply in China, how do we foresee stabilization in the Thailand plant's operations?

Answer: The product mix in Thailand differs from commodities produced in China, with unique grades that have higher margins. Our strong sales force and ongoing validations are designed to grow customer acceptance and demand. We've retained key customers quickly post-brand transition. Therefore, we are optimistic about increasing sales volumes despite the challenges inherent in brand validation.

5. Question: What impact does the phasing out of BIS regulations have on market competition?

Answer: There's minimal impact on market competition following BIS removal. We haven't observed any significant influx of imports as expected. Domestic demand remains strong, and while we acknowledge pricing pressures, our locally-produced products are valued for customization, delivery, and reliability. Thus, we've successfully enhanced our market share without damaging profit spreads.

6. Question: Can you confirm the current EBITDA projections and whether the losses incurred were exclusively from inventory valuation?

Answer: More than 75% of our losses in Thailand were attributed to inventory valuation. While we've adequately managed plant operations at higher utilization rates, reduced output in Q3 resulted in a drag on operational leverage. Although inventory adjustments are pivotal to understanding losses, most issues recognized stemmed from falling market prices rather than operational inefficiencies.

7. Question: Could you provide insight into the capex for FY '26 and clarify Thailand's contribution to consolidated revenue this quarter?

Answer: Our capex is primarily linked to the ABS expansion, estimated around INR350 crores, spilling into FY '27, funded through internal accruals. As for Thailand's financials, intercompany transactions are already accounted for, and figures reflect net positions, ensuring clarity in our performance reports. I assure you that these are conclusive adjustments made during consolidation.

Please let me know if you require any further details or another aspect of the earnings call!